Prognostic Implications of Parathyroid Hormone-Related Protein in Males and Females With Non-Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 197, doi. 10.1016/j.cllc.2011.03.018
- By:
- Publication type:
- Article
Works matching IS 15257304 AND DT 2011 AND VI 12 AND IP 3
Results: 12
1
2
Docetaxel Vs. Vinorelbine in Elderly Patients With Advanced Non-Small-Cell Lung Cancer: A Hellenic Oncology Research Group Randomized Phase III Study.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 155, doi. 10.1016/j.cllc.2011.03.015
- By:
- Publication type:
- Article
3
The Role of NF-E2-Related Factor 2 in Predicting Chemoresistance and Prognosis in Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 166, doi. 10.1016/j.cllc.2011.03.012
- By:
- Publication type:
- Article
4
Clinical Trials of Vascular Disrupting Agents in Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 143, doi. 10.1016/j.cllc.2011.03.010
- By:
- Publication type:
- Article
5
Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non-Small-Cell Lung Cancer (NSCLC)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
6
A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 161, doi. 10.1016/j.cllc.2011.03.013
- By:
- Publication type:
- Article
7
Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non-Small-Cell Lung Cancer (NSCLC).
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 172, doi. 10.1016/j.cllc.2011.03.019
- By:
- Publication type:
- Article
8
Frameless Image-Guided Stereotactic Body Radiation Therapy for Lung Tumors with 4-Dimensional Computed Tomography or 4-Dimensional Positron Emission Tomography/ Computed Tomography.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 180, doi. 10.1016/j.cllc.2011.03.014
- By:
- Publication type:
- Article
9
Clinical Value of Assaying Tumor Supplied Group of Factor/Tumor Specific Growth Factor in Patients With Solitary Pulmonary Nodule.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 192, doi. 10.1016/j.cllc.2011.03.017
- By:
- Publication type:
- Article
10
Scar Carcinoma of the Lung: A Historical Perspective.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 148, doi. 10.1016/j.cllc.2011.03.011
- By:
- Publication type:
- Article
11
A Phase II Study of Higher Dose Weekly Topotecan in Relapsed Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 187, doi. 10.1016/j.cllc.2011.03.016
- By:
- Publication type:
- Article
12
Clinical Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 1
- Publication type:
- Article